We are live on ! Find out more
HURA

TuHURA Biosciences
HURA

15 hedge funds and large institutions have $674K invested in TuHURA Biosciences in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

50% more capital invested

Capital invested by funds: $448K → $674K (+$226K)

50% more funds holding

Funds holding: 10 → 15 (+5)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
15
Holders Change
+5
Holders Change %
+50%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$391K
2
ECM
Evergreen Capital Management
Washington
+$35.1K
3
VF
Virtu Financial
New York
+$25.1K
4
Squarepoint
Squarepoint
New York
+$17.6K
5
Northern Trust
Northern Trust
Illinois
+$15K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$188K
2
IIA
IPG Investment Advisors
California
-$36.4K
3
Goldman Sachs
Goldman Sachs
New York
-$28K
4
UBS Group
UBS Group
Switzerland
-$7.52K
5
Two Sigma Investments
Two Sigma Investments
New York
-$5.01K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$349K +$391K +156 New
Renaissance Technologies
2
Renaissance Technologies
New York
$52K -$188K -75 -77%
RE
3
RBC Europe
United Kingdom
$48.2K +$12.5K +5 +29%
ECM
4
Evergreen Capital Management
Washington
$32K +$35.1K +14 New
Northern Trust
5
Northern Trust
Illinois
$28K +$15K +6 +86%
Vanguard Group
6
Vanguard Group
Pennsylvania
$25K +$2.51K +1 +10%
APA
7
Allegiant Private Advisors
Florida
$23K +$25.1K +10 New
Two Sigma Investments
8
Two Sigma Investments
New York
$22K -$5.01K -2 -17%
VF
9
Virtu Financial
New York
$22K +$25.1K +10 New
State Street
10
State Street
Massachusetts
$18K – – –
Squarepoint
11
Squarepoint
New York
$15K +$17.6K +7 New
FNB
12
Farmers National Bank
Kentucky
$14K +$15K +6 New
GSEP
13
Golden State Equity Partners
California
$14K +$15K +6 New
TRCT
14
Tower Research Capital (TRC)
New York
$10K +$10K +4 +400%
UBS Group
15
UBS Group
Switzerland
$1K -$7.52K -3 Closed
LC
16
Lindbrook Capital
California
$1K +$2.51K +1 New
IIA
17
IPG Investment Advisors
California
– -$36.4K -15 Closed
Goldman Sachs
18
Goldman Sachs
New York
– -$28K -11 Closed
TFS
19
TrustCore Financial Services
Tennessee
– -$1K – –

HURA Hedge Fund Activity: Q4 2020 in Review

15 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2020, worth a combined $674K — up 50% from $448K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new HURA positions and 3 closed out — a net gain of 5 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $391K. The largest seller was Renaissance Technologies, cutting an estimated $188K.

  • 15 institutional investors held TuHURA Biosciences (HURA) as of Q4 2020, up from 10 in Q3 2020.
  • Funds reported $674K of TuHURA Biosciences stock for Q4 2020, up 50% quarter-over-quarter.
  • 8 funds opened new TuHURA Biosciences positions in Q4 2020 and 3 closed out, a net change of +5 holders.
  • The largest TuHURA Biosciences buyer in Q4 2020 was Nantahala Capital Management, an estimated $391K added.
  • The largest TuHURA Biosciences seller in Q4 2020 was Renaissance Technologies, an estimated $188K sold.

Based on aggregated 13F filings for Q4 2020.